Insider filing · SUPN
Frank Mottola sold $1.0M of Supernus Pharmaceuticals (SUPN)
Executed Dec 19 2025, disclosed Dec 22 2025, 3 days later.
Value, as filed
$1.0M
20,000 sh across 2 lots
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 22 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FM
Frank Mottola
SVP, Quality, GMP, Ops, IT
profile →
Frank Mottola (SVP, Quality, GMP, Ops, IT) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.0M of SUPN (20,000 sh across 2 lots, as filed), executed Dec 19 2025.
The name
SUPN
SUPN
SUPN · 38 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Frank Mottola in SUPN
SUPNSALE
SUPERNUS PHARMACEUTICALS, INC.
$229K5,000 sh × $45.87
Exec Sep 12 2025
Filed Sep 15 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $623K
14,000 sh × $44.51
Exec Aug 25 2025
Filed Aug 27 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $555K
15,000 sh × $36.98
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET